GIM
AMGN icon

Glenmede Investment Management’s Amgen AMGN Stock Holding History

Glenmede Investment Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$32.8M Sell
116,342
-8,448
-7% -$2.45M 0.16% 120
2025
Q2 		$34.8M Buy
+124,790
New +$35.4M 0.18% 115

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Glenmede Investment Management's AMGN Position: Q3 2025 in Review

Glenmede Investment Management reduced its Amgen (AMGN) stake by 6.8% in Q3 2025, selling an estimated $2.45M and leaving 116,342 shares worth $32.8M. The position accounts for 0.16% of the portfolio, ranked #120.

Glenmede Investment Management first reported a position in AMGN in Q2 2025 and has held it in 2 quarters since. The position peaked at $34.8M in Q2 2025. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Glenmede Investment Management held 116,342 shares of Amgen worth $32.8M as of Q3 2025.
  • Glenmede Investment Management sold 8,448 Amgen shares in Q3 2025, an estimated $2.45M.
  • Amgen made up 0.16% of Glenmede Investment Management's portfolio in Q3 2025, its #120 holding.
  • Glenmede Investment Management first reported a position in Amgen in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Amgen position peaked at $34.8M in Q2 2025.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.